Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Pharmaceutics 15:452 Bojarska J, Mieczkowski A, Ziora ZM, Skwarczynski M, Toth I, Shalash AO, Parang K, El-Mowafi SA, Mohammed EH et al (2021) Cyclic dipeptides: the biological and structural landscape with special focus on the anti-cancer proline-based scaffold
As prostate cancer advances, symptoms may include difficulty urinating, a weak or interrupted urine flow, frequent urination (particularly at night), or blood in the urine or semen
PMID 30422501
Patients with controlled uric acid level and doing well on allopurinol would seem to have no reason to switch to this new agent, in view of allopurinol's lower cost and 40-year history of an overall very good safety record (see "Allopurinol" discussion above)
Ready to explore how Wolverine peptide therapy can support your healing and recovery
US$ 26.52
US$ 29.21
US$ 26.89
US$ 21.09
US$ 24.07
